Clinical Trials Directory

Trials / Completed

CompletedNCT05457673

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
AtaCor Medical, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The STEP IV Study is a prospective, single-center, non-randomized, single-arm study without concurrent or historical controls. The objective of the study is to generate safety and performance data of the latest AtaCor EV Temporary Pacing Lead System to support the development of a future pivotal study with an indication limited to a maximum of 7 days.

Detailed description

The primary safety objective is freedom from Adverse Device Effects (ADE). The primary performance objective is summary statistics for pacing capture threshold, impedance, and sensed R-wave amplitude with the StealthTrac Lead from insertion through removal. One (1) Investigational Site in Paraguay will participate with up to 16 subjects enrolled in the study. Subjects indicated for a closed-chest cardiac invasive procedure will be eligible for participation. Subjects undergoing a qualifying index procedure will have a Model AC-1013 StealthTrac Lead inserted and evaluated over the follow-up period (up to 7 days post procedure). Study participation requires 2 to 7 days with the Study Lead inserted. Following Study Lead removal, a final follow-up will be performed 27-33 days after lead insertion to assess for any latent Adverse Events. Subjects remain enrolled until completion of the 30-Day Follow Up. The maximum duration for study participation is 33 days. The Study is expected to last up to 3 months after first enrollment: Enrollment and follow-up (1 month) and final report (2 months).

Conditions

Interventions

TypeNameDescription
DEVICEAtaCor StealthTrac LeadSubjects will receive the AtaCor StealthTrac Lead being evaluated in the study.

Timeline

Start date
2022-08-17
Primary completion
2022-09-22
Completion
2022-10-20
First posted
2022-07-14
Last updated
2023-03-03

Locations

1 site across 1 country: Paraguay

Source: ClinicalTrials.gov record NCT05457673. Inclusion in this directory is not an endorsement.

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study (NCT05457673) · Clinical Trials Directory